https://www.selleckchem.com/products/borussertib.html 001), VWF/ADAMTS-13 (191 219 138;  = 0.003), FVIII (150% 144% 90%;  = 0.001) and TM (5.13 ng/ml 4.91 ng/mL 3.81 ng/ml;  < 0.001) were only increased in CD regardless of EA status when compared with controls. Lastly, ETP with and without TM remained the same in all three groups. CD patients in clinical remission with EA present endothelial lesion inducing TF exposure and subsequent coagulation cascade activation. Recommended thromboprophylaxis for EA outpatient subgroups will require additional investigation in order to be validated. CD patients in clinical remission with EA present endothelial lesion inducing TF exposure and subsequent coagulation cascade activation. Recommended thromboprophylaxis for EA outpatient subgroups will require additional investigation in order to be validated. It has been suggested that the a ( ) gene rs4762 (p.Thr174Met) polymorphism might be associated with myocardial infarction (MI) risk, but the study results are still debatable. . In order to explore the relationship between p.Thr174Met polymorphism and MI risk, the current meta-analysis involving 7657 subjects from 11 individual studies was conducted. A significant association between p.Thr174Met polymorphism and MI was found under recessive (OR 2.26, 95% CI 1.35-3.77, = 0.002), dominant (OR 1.131, 95% CI 1.016-1.260, = 0.024), codominant (OR 2.198, 95% CI 1.334-3.621, = 0.002), and additive (OR 1.363, 95% CI 1.132-1.641, = 0.001) genetic models. In the Asian subgroup, significantly increased MI risk was found under all genetic models ( < 0.05). No significant association between p.Thr174Met polymorphism and MI was found under all genetic models in the Caucasian subgroup ( > 0.05). p.Thr174Met variant might increase MI risk, especially within the Asian population. The Met174 allele of p.Thr174Met might confer the risk for MI. AGT p.Thr174Met variant might increase MI risk, especially within the Asian population. The Met174 allele